Concepedia

Răzvan Stoia

RS

Statistics

Publications

5

Citations

267

H-Index

5

Active since

2004

Affiliations

Institutul Clinic Fundeni(Current)

Răzvan Stoia is an author at Institutul Clinic Fundeni specializing in medicine, hematology, and oncology.

Publications per year

2004–2022

5

Publications

5

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

, , +15

Laparoscopic subtotal splenectomy in hereditary spherocytosis

Cătălin Vasilescu, Oana Stănciulea, Ștefan Tudor et al. · Surgical Endoscopy · 2006 · 49 citations

, , +2

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

, , +12

[Laparoscopic subtotal splenectomy in the treatment of hereditary spherocytosis].

Cătălin Vasilescu, Oana Stănciulea, Anca Coliţă et al. · PubMed · 2004 · 16 citations

, , +16

Primary Hepatic Marginal Zone Lymphoma in a Patient with Chronic Hepatitis C.

George Sebastian Gherlan, Răzvan Stoia, Mihaly Enyedi et al. · PubMed · 2016 · 15 citations

, , +17

1–5 of 5